Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 3Bachem AG
02 1Omgene Life Sciences Pvt. Ltd
03 1ChemWerth Inc
04 1LGM Pharma
05 1HRV Global Life Sciences
06 1Tofigh Daru
07 1USV Private Limited
08 1TAPI Technology & API Services
09 1Beijing Mesochem Technology
10 1ALP Pharm
11 1ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD
12 1Alembic Pharmaceuticals Limited
13 1AmbioPharm
14 1Auro Peptides Limited
15 1Aurobindo Pharma Limited
16 1BCN Peptides
17 1CBL- Chemical and Biopharmaceutical Laboratories
18 1Chemi SpA
19 1Chengdu Shengnuo Biopharm
20 1Fresenius Kabi AB Brunna
21 1Hainan Shuangcheng Pharmaceuticals
22 1Hamari chemicals
23 1Hanways Chempharm
24 1Hybio Pharmaceutical
25 1Jiangsu Sinopep Allsino Biopharmaceutical
26 1Jin Dun Medical
27 2Piramal Pharma Solutions
28 3PolyPeptide Group
29 1ScinoPharm Taiwan, Ltd
30 1Shenzhen JYMed Technology
31 1Shilpa Medicare
32 1Smaart Pharmaceutticals
33 2Sun Pharmaceutical Industries Limited
34 1Suzhou Tianma Pharma Group Co Ltd
35 1Tecoland Corporation
36 1Teva Pharmaceutical Industries
37 1Tianish Laboratories
38 1Unipex
39 1Viatris
40 1Wockhardt
41 1Blank
01 11China
02 1France
03 1Greece
04 12India
05 1Iran
06 2Israel
07 1Italy
08 1Japan
09 1Spain
10 1Sweden
11 6Switzerland
12 1Taiwan
13 7U.S.A
14 1Blank
01 24Active
02 3Inactive
03 20Blank
01 8Valid
02 39Blank
01 1226MF10055
02 1226MF10062
03 1227MF10055
04 1306MF10083
05 43Blank
01 1WC-0012
02 1WC-0047
03 1WC-0159
04 1WC-0237
05 1WC-0443
06 42Blank
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-09-09
Pay. Date : 2014-04-10
DMF Number : 16760
Submission : 2003-08-13
Status : Active
Type : II
Certificate Number : R0-CEP 2020-229 - Rev 01
Issue Date : 2022-07-18
Type : Chemical
Substance Number : 2414
Status : Valid
Registration Number : 306MF10083
Registrant's Address : Hauptstrasse 144,4416 Bubendorf Switzerland
Initial Date of Registration : 2024-07-03
Latest Date of Registration : --
NDC Package Code : 52416-109
Start Marketing Date : 2018-04-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Tofigh Daru develops & synthesizes a diverse range of APIs in Anticancer, Narcotics, Cardiovascular to Immunomodulatory Segments.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-07-16
Pay. Date : 2013-02-27
DMF Number : 24288
Submission : 2010-11-01
Status : Active
Type : II
Date of Issue : 2022-06-27
Valid Till : 2025-06-02
Written Confirmation Number : WC-0012
Address of the Firm :
NDC Package Code : 62147-0206
Start Marketing Date : 2010-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : BULK INGREDIENT
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-02-27
Pay. Date : 2012-11-09
DMF Number : 17777
Submission : 2004-10-21
Status : Active
Type : II
Available Reg Filing : ASMF |
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-11-19
Pay. Date : 2019-09-19
DMF Number : 34145
Submission : 2019-09-27
Status : Active
Type : II
NDC Package Code : 52416-109
Start Marketing Date : 2018-04-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38662
Submission : 2023-10-23
Status : Active
Type : II
NDC Package Code : 52416-109
Start Marketing Date : 2018-04-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30131
Submission : 2015-12-24
Status : Active
Type : II
NDC Package Code : 65129-1049
Start Marketing Date : 2014-03-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-02-26
Pay. Date : 2020-11-24
DMF Number : 34118
Submission : 2020-12-21
Status : Active
Type : II
NDC Package Code : 66558-0192
Start Marketing Date : 2021-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-01-05
Pay. Date : 2016-09-27
DMF Number : 30249
Submission : 2016-09-20
Status : Active
Type : II
Certificate Number : R0-CEP 2021-365 - Rev 00
Issue Date : 2022-10-26
Type : Chemical
Substance Number : 2414
Status : Valid
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-07
Pay. Date : 2013-12-09
DMF Number : 27729
Submission : 2013-12-20
Status : Active
Type : II
NDC Package Code : 65015-840
Start Marketing Date : 2015-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37913
Submission : 2022-12-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19567
Submission : 2006-06-28
Status : Active
Type : II
Registration Number : 226MF10055
Registrant's Address : Viale dei Laboratori 54, 20092 Cinisello Balsamo (Milano) ITALY
Initial Date of Registration : 2014-03-06
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14994
Submission : 2000-08-04
Status : Active
Type : II
Certificate Number : R0-CEP 2021-279 - Rev 00
Issue Date : 2022-04-29
Type : Chemical
Substance Number : 2414
Status : Valid
Date of Issue : 2019-06-27
Valid Till : 2022-06-26
Written Confirmation Number : WC-0047
Address of the Firm :
NDC Package Code : 59149-007
Start Marketing Date : 2023-02-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (6g/6g)
Marketing Category : BULK INGREDIENT
Registrant Name : Meditip Co., Ltd.
Registration Date : 2022-07-11
Registration Number : 20220711-210-J-1331
Manufacturer Name : PolyPeptide Laboratories Pvt. Ltd
Manufacturer Address : Plot No. K28, Addtional MIDC, Anandnagar, Ambernath(E), Thane 421 506, Maharashtra State, India
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-04-12
Pay. Date : 2018-06-13
DMF Number : 32863
Submission : 2018-06-18
Status : Active
Type : II
NDC Package Code : 59149-007
Start Marketing Date : 2023-02-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (6g/6g)
Marketing Category : BULK INGREDIENT
Registrant Name : Meditip Co., Ltd.
Registration Date : 2022-07-11
Registration Number : 20220711-210-J-1331
Manufacturer Name : PolyPeptide Laboratories Pvt. Ltd
Manufacturer Address : Plot No. K28, Addtional MIDC, Anandnagar, Ambernath(E), Thane 421 506, Maharashtra State, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30992
Submission : 2016-10-26
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-08-02
Pay. Date : 2017-03-06
DMF Number : 31277
Submission : 2016-12-16
Status : Active
Type : II
NDC Package Code : 84147-001
Start Marketing Date : 2024-03-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17678
Submission : 2004-09-15
Status : Active
Type : II
Registration Number : 226MF10062
Registrant's Address : SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, Maharashtra, India
Initial Date of Registration : 2014-03-06
Latest Date of Registration : --
Date of Issue : 2022-06-08
Valid Till : 2025-07-25
Written Confirmation Number : WC-0159
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-05
Pay. Date : 2014-02-21
DMF Number : 27990
Submission : 2014-03-01
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-01-04
Pay. Date : 2021-11-26
DMF Number : 35816
Submission : 2021-11-26
Status : Active
Type : II
NDC Package Code : 52958-117
Start Marketing Date : 2024-05-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (500g/500g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18740
Submission : 2005-09-08
Status : Active
Type : II
NDC Package Code : 35207-0002
Start Marketing Date : 2013-11-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-08-24
Pay. Date : 2015-06-17
DMF Number : 29448
Submission : 2015-06-20
Status : Active
Type : II
Date of Issue : 2022-09-07
Valid Till : 2025-06-10
Written Confirmation Number : WC-0443
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-07-11
Pay. Date : 2022-06-30
DMF Number : 36322
Submission : 2021-11-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22068
Submission : 2008-10-08
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21704
Submission : 2008-06-13
Status : Inactive
Type : II
NDC Package Code : 59149-007
Start Marketing Date : 2023-02-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (6g/6g)
Marketing Category : BULK INGREDIENT
Registrant Name : Meditip Co., Ltd.
Registration Date : 2022-07-11
Registration Number : 20220711-210-J-1331
Manufacturer Name : PolyPeptide Laboratories Pvt. Ltd
Manufacturer Address : Plot No. K28, Addtional MIDC, Anandnagar, Ambernath(E), Thane 421 506, Maharashtra State, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26330
Submission : 2012-06-13
Status : Inactive
Type : II
Date of Issue : 2019-09-03
Valid Till : 2022-09-02
Written Confirmation Number : WC-0237
Address of the Firm :
A Octreotide Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Octreotide Acetate, including repackagers and relabelers. The FDA regulates Octreotide Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Octreotide Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Octreotide Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Octreotide Acetate supplier is an individual or a company that provides Octreotide Acetate active pharmaceutical ingredient (API) or Octreotide Acetate finished formulations upon request. The Octreotide Acetate suppliers may include Octreotide Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Octreotide Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 40 companies offering Octreotide Acetate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?